Visual outcome in patients with acute invasive fungal rhinosinusitis

Abstract

Acute invasive fungal rhinosinusitis (AIFRS) is an aggressive disease with fatal complications. The mortality rate of AIFRS ranges between 49 and 62%. The incidence of visual loss in AIFRS has been reported to be between 26 and 29%. A total of 5/16 patients in our study showed improvement in vision after treatment in 1 year follow-up while 11 patients showed no improvement in visual acuity. The AIFRS with visual loss is managed using systemic amphotericin B with a combination of surgical debridement.